Comments
Loading...

Apyx Medical Analyst Ratings

APYXNASDAQ
Logo brought to you by Benzinga Data
$3.87
-0.13-3.13%
Last update: Dec 12, 12:42 PM
Consensus Rating1
Overweight
Highest Price Target1
$9.00
Lowest Price Target1
$4.50
Consensus Price Target1
$6.63

Apyx Medical Analyst Ratings and Price Targets | NASDAQ:APYX | Benzinga

Apyx Medical Corp has a consensus price target of $6.63 based on the ratings of 6 analysts. The high is $9 issued by Lake Street on June 15, 2023. The low is $4.5 issued by Piper Sandler on August 11, 2023. The 3 most-recent analyst ratings were released by Citizens, Stephens & Co., and Piper Sandler on November 12, 2025, November 10, 2023, and August 11, 2023, respectively. With an average price target of $5.83 between Citizens, Stephens & Co., and Piper Sandler, there's an implied 50.93% upside for Apyx Medical Corp from these most-recent analyst ratings.

Analyst Trends and Forecast

0
0
0
0
Nov
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Citizens
Stephens & Co.
Piper Sandler
Lake Street

1calculated from analyst ratings

Analyst Ratings for Apyx Medical

Get Alert
Nov 12, 2025
106.99%
8
Previous
Market Perform
Current
Market Outperform
Get Alert
Oct 17, 2024
—
—
Previous
Initiates
Current
Neutral
Get Alert
Sep 16, 2024
—
—
Previous
Current
Market Perform
Get Alert
Nov 10, 2023
29.37%
5
8
Previous
Overweight
Current
Overweight
Get Alert
Aug 11, 2023
16.43%
4
4.5
Previous
Overweight
Current
Overweight
Get Alert
Jul 14, 2023
106.99%
8
Previous
Initiates
Current
Overweight
Get Alert
Jun 15, 2023
132.86%
6
9
Previous
Current
Buy
Get Alert
May 24, 2023
—
—
Previous
Current
Market Perform
Get Alert
May 12, 2023
55.24%
5
6
Previous
Buy
Current
Buy
Get Alert

FAQ

Q

What is the target price for Apyx Medical (APYX) stock?

A

The latest price target for Apyx Medical (NASDAQ:APYX) was reported by Citizens on November 12, 2025. The analyst firm set a price target for $8.00 expecting APYX to rise to within 12 months (a possible 106.99% upside). 1 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Apyx Medical (APYX)?

A

The latest analyst rating for Apyx Medical (NASDAQ:APYX) was provided by Citizens, and Apyx Medical upgraded their market outperform rating.

Q

When was the last upgrade for Apyx Medical (APYX)?

A

The last upgrade for Apyx Medical Corp happened on November 12, 2025 when Citizens raised their price target to $8. Citizens previously had a market perform for Apyx Medical Corp.

Q

When was the last downgrade for Apyx Medical (APYX)?

A

There is no last downgrade for Apyx Medical.

Q

When is the next analyst rating going to be posted or updated for Apyx Medical (APYX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Apyx Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Apyx Medical was filed on November 12, 2025 so you should expect the next rating to be made available sometime around November 12, 2026.

Q

Is the Analyst Rating Apyx Medical (APYX) correct?

A

While ratings are subjective and will change, the latest Apyx Medical (APYX) rating was a upgraded with a price target of $0.00 to $8.00. The current price Apyx Medical (APYX) is trading at is $3.87, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.